Cargando…

Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success

PURPOSE: This study aims to determine local diagnostic reference levels (LDRLs) of intra-arterial chemotherapy (IAC) procedures of pediatric patients with retinoblastoma (RB) to provide data for establishing diagnostic reference levels (DRLs) in pediatric interventional radiology (IR). METHODS: In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Opitz, Marcel, Bos, Denise, Deuschl, Cornelius, Radbruch, Alexander, Zensen, Sebastian, Sirin, Selma, Forsting, Michael, Bechrakis, Nikolaos, Biewald, Eva, Bornfeld, Norbert, Ketteler, Petra, Timmermann, Beate, Stuschke, Martin, Guberina, Maja, Wetter, Axel, Göricke, Sophia, Guberina, Nika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880957/
https://www.ncbi.nlm.nih.gov/pubmed/32862237
http://dx.doi.org/10.1007/s00234-020-02540-7
Descripción
Sumario:PURPOSE: This study aims to determine local diagnostic reference levels (LDRLs) of intra-arterial chemotherapy (IAC) procedures of pediatric patients with retinoblastoma (RB) to provide data for establishing diagnostic reference levels (DRLs) in pediatric interventional radiology (IR). METHODS: In a retrospective study design, LDRLs and achievable dose (AD) were assessed for children undergoing superselective IAC for RB treatment. All procedures were performed at the flat-panel angiography systems (I) ArtisQ biplane (Siemens Healthineers) and (II) Allura Xper (Philips Healthcare). Patients were differentiated according to age (A1: 1–3 months; A2: 4–12 months; A3: 13–72 months; A4: 73 months–10 years; A5: > 10 years), sex, conducted or not-conducted chemotherapy. RESULTS: 248 neurointerventional procedures of 130 pediatric patients (median age 14.5 months, range 5–127 months) with RB (68 unilateral, 62 bilateral) could be included between January 2010 and March 2020. The following diagnostic reference values, AD, and mean values could be determined: (A2) DRL 3.9 Gy cm(2), AD 2.9 Gy cm(2), mean 3.5 Gy cm(2); (A3) DRL 7.0 Gy cm(2), AD 4.3 Gy cm(2), mean 6.0 Gy cm(2); (A4) DRL 14.5 Gy cm(2), AD 10.7 Gy cm(2), mean 10.8 Gy cm(2); (A5) AD 8.8 Gy cm(2), mean 8.8 Gy cm(2). Kruskal-Wallis-test confirmed a significant dose difference between the examined age groups (A2–A5) (p < 0.001). There was no statistical difference considering sex (p = 0.076) and conducted or not-conducted chemotherapy (p = 0.627). A successful procedure was achieved in 207/248 cases. CONCLUSION: We report on radiation exposure during superselective IAC of a pediatric cohort at the German Retinoblastoma Referral Centre. Although an IAC formally represents a therapeutic procedure, our results confirm that radiation exposure lies within the exposure of a diagnostic interventional procedure. DRLs for superselective IAC are substantially lower compared with DRLs of more complex endovascular interventions.